Hans Bojar
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 5%
- HER2/EGFR in Cancer Research
Papers in
-
- Breast Cancer Treatment Studies 20
- Cancer Genomics and Diagnostics 8
- Genetics 30
- Estrogen and related hormone effects 23
- Co-authors
- Olga ModlichWerner AudretschWilli SauerbreiClaudia SchmoorW. StaibMartin SchumacherThomas SchnabelMahdi Rezai
- Journals
- Clinical Chemistry and Laboratory Medicine (CCLM) (5 papers)European Journal of Cancer (4 papers)Journal of Clinical Oncology (4 papers)Clinical Cancer Research (3 papers)British Journal of Cancer (3 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Hans Bojar
92 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 122
- Cancer Research 557
- Oncology 580
- Biological Psychiatry 40
- Statistics and Probability 113
- Pathology and Forensic Medicine 208
Countries citing papers authored by Hans Bojar
This map shows the geographic impact of Hans Bojar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Bojar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Bojar more than expected).
Fields of papers citing papers by Hans Bojar
This network shows the impact of papers produced by Hans Bojar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Bojar. The network helps show where Hans Bojar may publish in the future.
Co-authors
The 25 scholars most cited alongside Hans Bojar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 18 | |
| 2 | 2015 | 1 | |
| 3 | 2014 | 11 | |
| 4 | 2012 | 16 | |
| 5 | 2010 | 108 | |
| 6 | 2010 | 41 | |
| 7 | 2009 | 0 | |
| 8 | Predictive biological markers for response of invasive breast cancer to anthracycline/cyclophosphamide-based primary (radio-)chemotherapy. | 2006 | 33 |
| 9 | 2003 | 10 | |
| 10 | 2002 | 18 | |
| 11 | 2002 | 47 | |
| 12 | 2000 | 11 | |
| 13 | 2000 | 10 | |
| 14 | 1999 | 69 | |
| 15 | 1994 | 1 | |
| 16 | Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter study. | 1986 | 73 |
| 17 | 1985 | 3 | |
| 18 | Gradient centrifugation analysis of steroid-hormone binding in human malignant melanoma. | 1982 | 5 |
| 19 | 1979 | 3 | |
| 20 | 1979 | 15 |
About Hans Bojar
Hans Bojar is a scholar working on Cancer Research, Genetics, Oncology, Pathology and Forensic Medicine and Biotechnology, having authored 97 papers that have together received 2.0k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (23 papers), Breast Cancer Treatment Studies (20 papers), Cancer Genomics and Diagnostics (8 papers), Breast Lesions and Carcinomas (8 papers), Cancer Cells and Metastasis (7 papers), HER2/EGFR in Cancer Research (7 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Cancer Research and Treatments (5 papers). The work is most often cited by research in Cancer Research (557 citations), Oncology (580 citations), Biological Psychiatry (40 citations), Statistics and Probability (113 citations) and Pathology and Forensic Medicine (208 citations). Hans Bojar has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Olga Modlich, Werner Audretsch, Willi Sauerbrei, Claudia Schmoor, W. Staib, Martin Schumacher, Thomas Schnabel, Mahdi Rezai, Nikolaos Zamboglou and Christos Kolotas. Their work appears in journals such as Clinical Chemistry and Laboratory Medicine (CCLM), European Journal of Cancer, Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.